Physician profile
Ruben Jose Rivera Rivera
NPI 1639565955
$2,131.83
in general payments reported to CMS, 2019-2025
13 companies · $726 in 2025
The $726 reported for 2025 was more than what 88% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $949 · 2023: $334 · 2024: $124 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087 · Travel and Lodging: $95.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.28 |
| Travel and Lodging | $95.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $774.97 | 2022-2023 | Painteq |
| Boston Scientific Corporation | $502.16 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16, General - Therapies |
| Abbott Laboratories | $305.65 | 2024-2025 | Eterna, Proclaim |
| Scilex Pharmaceuticals INC. | $140.14 | 2022-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.39 | 2022-2023 | Relistor |
| Abbvie INC. | $59.98 | 2023-2025 | Qulipta, Ubrelvy |
| Neurometrix INC | $58.07 | 2023 | |
| Collegium Pharmaceutical, INC. | $57.77 | 2022 | |
| Curonix LLC | $39.93 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $29.94 | 2022 | |
| Mvp Orthopedics INC | $28.50 | 2022 | |
| Relievant Medsystems, INC. | $18.98 | 2022 | |
| Averitas Pharma INC. | $18.35 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Rivera Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.